drugset / Trial / NCT03606824

Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)

NCT03606824

RandomizedParallel-groupTriple-blindTreatment

Summary

In ASCVD patients complicated with subclinical hypothyroidism, the percentage of those who did not reach the target of lipid-lowering therapy (LDL-C\>1.8mmol/L) is usually higher than that in population with normal thyroid function. The present study aims to randomly compare two lipid-lowering therapeutic strategies (statins only vs. statins combined with thyroid hormone supplement).

Timeline

Start
2019-03-25
Primary completion
2020-02-28
Completion
2020-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Levothyroxine Other / unclassified 12.5 ug
Comparator Pitavastatin Small molecule 2 mg
Comparator Pitavastatin Small molecule 4 mg